About AVT
Browse Articles
Authors
Customer Services

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please note that the journal is running later than expected due to COVID-19.

During the transition, you can still access content to which you have subscribed via the AVT website. Content will be available to access via the SAGE Journals platform in Summer 2021. https://uk.sagepub.com/en-gb/eur/antiviraltherapy.

If you have any questions relating to the transfer, please contact journaltransitions@sagepub.com

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Subscriptions Please note that Antiviral Therapy is running later than expected due to COVID-19.

All subscription queries should be sent to subscriptions@sagepub.co.uk

Orders via subscription agents
If you are using a subscription agent, please instruct your agent as usual. We are notifying all subscription agents of this change of publisher and they will be able to handle your query.

Pricing enquiries 2021 Antiviral Therapy pricing set by International Medical Press will be honoured.

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please continue to submit your manuscripts to the AVT ScholarOne site (https://mc.manuscriptcentral.com/avt)

For papers already in peer-review, you will be informed of a decision as soon as possible. All accepted papers not assigned to a 2020 issue will now be published by SAGE.

Submit to AVT

Antiviral Therapy welcomes high-quality research on the clinical development and use of antiviral agents and vaccines, and the treatment of all virus diseases.

Before submitting your manuscript, please read our Author Guidelines to ensure your paper meets the format and content requirements to be considered for publication in Antiviral Therapy.

All manuscripts should be submitted through our online portal using ScholarOne Manuscripts™.
We do not accept manuscripts by post or email.

Benefits of our online submission include
♦ Easy to follow step-by-step submission
♦ Ability to track manuscripts through every stage of the peer-review process
♦ Helpful automated reminders of deadlines.

If you have any questions regarding online submission, author guidelines or the status of your manuscript, please contact our Editorial Office.

 

Copyright © 2021 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.